United Services Automobile Association Sarepta Therapeutics, Inc. Transaction History

United Services Automobile Association

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$72.81 - $156.91 $804,259 - $1.73 Million	-11,046 Closed	0 $0
Q2 2019 Aug 16, 2019	SELL	$112.21 - $151.95 $18,963 - $25,679	-169 Reduced 1.51%	11,046 $1.68 Million
Q1 2019 May 13, 2019	BUY	$106.67 - $151.68 $2,560 - $3,640	24 Added 0.21%	11,215 $1.34 Million
Q4 2018 Feb 13, 2019	BUY	$97.32 - $148.76 $128,462 - $196,363	1,320 Added 13.37%	11,191 $1.22 Million
Q3 2018 Nov 13, 2018	BUY	$115.31 - $161.51 $48,084 - $67,349	417 Added 4.41%	9,871 $1.59 Million
Q2 2018 Sep 27, 2018	SELL	$71.74 - $153.69 $22.4 Million - $47.9 Million	-311,572 Reduced 97.06%	9,454 $1.25 Million
Q2 2018 Aug 10, 2018	BUY	$71.74 - $153.69 $22.4 Million - $47.9 Million	311,572 Added 3295.66%	321,026 $19.6 Million
Q1 2018 May 14, 2018	BUY	$54.02 - $82.27 $510,705 - $777,780	9,454 New	9,454 $700,000

530

84.5M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.